Next Article in Journal
Barriers towards Sun Exposure and Strategies to Overcome These Barriers in Female Indoor Workers with Insufficient Vitamin D: A Qualitative Approach
Next Article in Special Issue
The Role of Micronutrients in Support of the Immune Response against Viral Infections
Previous Article in Journal
Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials
Previous Article in Special Issue
Carrot Pomace Polysaccharide (CPP) Improves Influenza Vaccine Efficacy in Immunosuppressed Mice via Dendritic Cell Activation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 12
Issue 10
10.3390/nu12102992
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Effective Immune Functions of Micronutrients against SARS-CoV-2

by
Kashaf Junaid
1,*,
Hasan Ejaz
1,
Abualgasim Elgaili Abdalla
1,2,
Khalid O. A. Abosalif
1,2,
Muhammad Ikram Ullah
1,
Humaira Yasmeen
3,
Sonia Younas
4,
Sanaa S. M. Hamam
5,6 and
Abdul Rehman
7
1
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Al Jouf, Saudi Arabia
2
Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Omdurman Islamic University, Omdurman 14415, Sudan
3
Department of Microbiology and Molecular Genetics, The Women University Multan, Multan 60000, Pakistan
4
Department of Pathology, Tehsil Headquarter Hospital Kamoke, District Gujranwala, Kamoke 50661, Pakistan
5
Department of Medical Microbiology and Immunology, Faculty of Medicine, Menoufia University, Shebin El-koom 32511, Egypt
6
Department of Microbiology, King Abdulaziz Specialist Hospital, Sakaka 72341, Saudi Arabia
7
Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore 54590, Pakistan
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(10), 2992; https://doi.org/10.3390/nu12102992
Submission received: 13 September 2020 / Revised: 26 September 2020 / Accepted: 28 September 2020 / Published: 29 September 2020
(This article belongs to the Special Issue Nutrition, Immunity and Viral Infection)
Browse Figures
Versions Notes

Abstract

:
The third coronavirus outbreak in the last two decades has caused significant damage to the world’s economy and community health. The highly contagious COVID-19 infection has affected millions of people to date and has led to hundreds of thousands of deaths worldwide. Aside from the highly infectious nature of SARS-CoV-2, the lack of a treatment or vaccine has been the main reason for its spread. Thus, it has become necessary to find alternative methods for controlling SARS-CoV-2. For the present review, we conducted an online search for different available nutrition-based therapies for previously known coronavirus infections and RNA-based virus infections as well as general antiviral therapies. These treatments have promise for combating COVID-19, as various nutrients and minerals play direct and indirect roles in the control and prevention of this newly emerged viral infection. The patients’ nutritional status with COVID-19 must be analyzed before administering any treatment, and nutritional supplements should be given to the affected individuals along with routine treatment. We suggest a potential interventional role of nutrients to strengthen the immune system against the emerging infection caused by COVID-19.

1. Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family of coronaviruses (CoVs), is the causative agent of pandemic coronavirus disease 2019 (COVID-19). There are four subfamilies of Coronaviridae, including the α, β, γ, and δ coronaviruses [1]. SARS-CoV-2 is a β-coronavirus and has a positive-sense single-stranded RNA genome [2]. CoVs can cross the species barrier and jump from mammals and birds to humans. The previous outbreaks of CoVs include those that caused the Middle East respiratory syndrome (2012) and severe acute respiratory syndrome (2002), known as MERS and SARS, respectively [3]. In December 2019, a flulike novel coronavirus, named SARS-CoV-2 and later found to be closely related to the MERS and SARS CoVs, emerged in Wuhan, China [4]. The World Health Organization (WHO) declared COVID-19 to be pandemic a month after its first outbreak because of the extremely high morbidity and mortality rates worldwide.
Presently, most of the drugs and vaccines for treating and preventing COVID-19 are still under trial, while the number of infected individuals continues to rise. There is no definite therapy for this novel infection, making it necessary to identify other options to control and prevent the escalating number of cases. An alternative approach that may help to combat this virus is to optimize the immune system. Many scientists have stressed the importance of nutritional intervention to improve the immune response. A well-balanced diet is essential for maintaining immune homeostasis. Any micronutrient deficiency may hinder the immune response against pathogens [5]. The ability of nutrients to protect against many infectious diseases and their role in reducing lung damage in pulmonary infections have been established in recent studies [6,7].
This review emphasizes micronutrients’ role in the development and efficient functioning of the immune system, primarily the antiviral defense system. We carried out an online search in PubMed for this review using the keywords coronaviruses, MERS, SARS, nutrients, and minerals. We included a total of 107 online studies, and none of the studies were used in our work other than accessible online. We summarized the general findings on the inhibitory actions of certain minerals and vitamins and proposed guidelines that can be used for COVID-19 prevention and therapy. We anticipate that these nutrients will aid in combating the newly emerging viral infection [8].

2. COVID-19 and the Immune Response

Based on the clinical manifestations, patients with COVID-19 are divided into three groups, presymptomatic, asymptomatic, and symptomatic [9]. The reasons why some develop severe disease and others do not are not entirely known; however, the immune system of an infected individual is one of the primary factors. When a virus infects an individual, a specific immune response is triggered, which is essential to eradicate the virus and prevent its progression. If the host immune system is weak, the virus will propagate and cause extensive tissue damage, especially in organs that express angiotensin-converting enzyme 2 (ACE2) receptors [10].
For the virus to enter host cells, the receptor-binding domain (RBD) of the viral spike protein binds to ACE2 receptors on host cells [10,11]. The virus can be taken up by antigen-presenting cells (APCs) such as dendritic cells and macrophages, which present it to the T cells. APCs contribute to the activation and differentiation of T cells and later to the massive release of cytokines. The host’s natural immune system recognizes viral components through pattern recognition receptors (PRRs) such as toll-like receptors (TLRs). Binding to TLRs induces the expression of inflammatory factors that can mediate lung inflammation and fibrosis [12,13].
Mast cells serve as a protective barrier against pathogens, and they also can be activated by a viral infection. Activated mast cells release histamines and proteases and trigger the release of proinflammatory markers, including IL-1, IL-6, and IL-33 [14]. These events lead to the activation of T cells and the massive release of cytokines, contributing to the amplification of the immune response. CD4+ or helper T cells stimulate the synthesis of virus-specific antibodies by activating B cells, whereas the function of CD8+ cells or cytotoxic T cells is to kill the virus-infected cells [12]. T helper cells also release chemokines and cytokines and provide signals to help monocytes and neutrophils reach the infected site, as shown in Figure 1 [15,16]. The extensive release of proinflammatory cytokines is known as a cytokine storm, leading to acute respiratory distress syndrome (ARDS) in these patients [17]. A primary cause of the high fatality rate of COVID-19 is the development of ARDS. The immediate release of free radicals and cytokines significantly increases oxidative stress, which is a hallmark of ARDS, causing cellular injury, multiple organ failure, and eventually death.

3. Nutritional Interventions for Treatment of COVID-19

Healthy and balanced nutrition is linked with strong immunity, and it represents our most potent tool in the ongoing COVID-19 crisis. Generally, poorly nourished individuals are at a higher risk of developing various types of infections [18]. Moreover, chronic and severe infections can cause nutritional disorders and worsen a patient’s nutritional status, making them susceptible to other infections. Thus, especially during the COVID-19 pandemic, it is imperative for everyone to monitor their diet and nutritional status [19]. Recent reports have identified certain groups at higher risk of COVID-19-associated complications, with the elderly and individuals with comorbidities such as hypertension, diabetes, and cancer more severely affected [20,21,22]. These risk factors are associated with malnutrition, which may alter the health status of the individuals.
In the absence of a specific antiviral therapy for SARS-CoV-2, several supportive and adjunct treatments are recommended. These include corticosteroid, ascorbic acid, anti-inflammatory, and interleukin-directed therapies. The overall aim is to manage the cytokine storm and the progression of infection [23]. The limited number of studies on the supportive care management of COVID-19 cases state that nutritional status should be assessed in all patients at the time of hospital admission. It is recommended that nutritional support be given to those in the high-risk group, asymptomatic carriers, and patients with moderate or severe COVID disease [24]. A variety of micronutrients strategies to treat COVID-19 have reached the clinical trial stage (Table 1). The immediate supplementation of certain nutrients in mild cases can prevent the progression of diseases.
Micronutrient deficiencies suppress the immune system by altering the T cell- and antibody-mediated immune response and dysregulating the host immune system [25]. A balanced diet includes healthy portions of vegetables, fruits, nuts, legumes, whole grains, and moderate levels of dairy, fish, and poultry. It is recommended to limit the intake of sugar, refined carbohydrates, processed foods, and red meat. The fats consumed should include olive oils [26,27]. The rationale behind such a diet is that it will provide the necessary amount of healthy macronutrients, essential vitamins, and minerals and ensure an excellent metabolic state and maintain a healthy body weight [28]. Healthy eating provides necessary vitamins and minerals that produce sufficient numbers of immune cells and antibodies, resulting in better immunity, which prepares the body to fight off infections.

4. Minerals and Immune System

4.1. Zinc

Zinc is a necessary mineral found in various fruits and vegetables. It plays a vital role in the maintenance and growth of adaptive and innate immune cells [29]. Zinc deficiency results in immune system dysfunction, which increases the susceptibility to infections and diseases [30]. Various studies have highlighted the role of zinc in preventing respiratory tract infections. It has been documented that zinc supplementation in children infected with measles who were zinc deficient reduced the morbidity and mortality associated with lower respiratory tract infections [31]. Recent studies have shown that increasing the concentration of intracellular zinc markedly reduces the replication of different types of RNA viruses [32]. Zinc supplementation in cases of hepatitis C and human papillomavirus infection has been shown to result in clinical improvement [33]. It has been reported that an amalgamation of low concentration zinc and zinc-ionophores retards the replication of SARS-CoVs in vitro [34].
Another approach to the treatment of COVID-19 infection is to target ACE2 receptors. SARS-CoV-2 requires ACE2 receptors to enter host cells; therefore, it is thought that these receptors are potential therapeutic sites [35]. Speth et al. found that the activity of recombinant human ACE2 in rat lungs was reduced when exposed to zinc (100 µM) [36,37]. In a recent case study, significant improvement was observed in four confirmed COVID-19 patients when treated with a high dose of zinc salt [38]. The use of zinc supplements may help to relieve COVID-19-related symptoms.
The primary defensive mechanism by which zinc protects against bacterial and viral infections is its role as an antioxidant. Adequate zinc levels in the body protect against oxidative stress caused by reactive oxygen species (ROS) [39]. Zinc deficiency promotes the production of proinflammatory cytokines and is linked with the inflammatory alteration of lung predispose to fibrosis [40]. Supplementation of a moderate dose of zinc has been shown to correct the overproduction of proinflammatory cytokines in the elderly caused by zinc deficiency [41]. It also stimulates the proliferation of immune cells that function to remove foreign entities and prevent infections. Zinc also plays a structural role in the body in maintaining the integrity of membranes and the skin [42]. It mediates the development and function of immune cells. Zinc is involved in adaptive immunity by participating in the T lymphocytes’ development by promoting the binding of certain regulatory enzymes to T cells [39].

4.2. Iron

Iron is a necessary nutrient and contributes substantially to the development of immunity [43]. Iron deficiency can impair host immunity, as various immune system cells need iron for their growth and development. However, higher doses of iron can also lead to oxidative stress, creating a suitable environment for inducing harmful viral mutations [44,45]. In the context of the current COVID-19 pandemic, maintaining sufficient levels of iron could be useful, as iron deficiency can increase the risk of recurring acute respiratory tract infections [46]. Iron contributes to the upregulation of the immune response but dysregulates iron homeostasis that regulates proinflammatory cytokine production. It can mediate the synthesis of enzymes crucial for immune cell generation, including ribonucleotide reductase, which carries out DNA synthesis. Iron can generate hydroxyl radicals, which help neutrophils to kill viruses and bacteria [42]. It stimulates the synthesis of ROS for destroying pathogens and inducing the differentiation of T lymphocytes [47].
A retrospective analysis in the COVID-19 hospitalized patients indicates that most patients suffering from functional iron deficiency are significantly linked with progressive inflammation and prolonged hospital stay [48].

4.3. Selenium

Selenium (Se) is an important element that is required only in trace amounts in the body. Selenium content present in food products based on the amount of selenium existing in the soil. So, the amount in similar food item varies in different geographical locations. However, the primary sources for this element are meat, bread, mushrooms, dairy products, fish, seafood, and nuts [49,50,51]. It acts as an enzyme cofactor that takes part in mammalian redox reactions [52]. Because the host’s nutritional condition is crucial in protecting against various diseases [53], deficiencies in various nutrients influence the immune reaction and the viral infection [54].
A selenium-deficient diet can lead to increased oxidative stress in the body, resulting in mutating the viral genome and possibly transforming a benign virus into a highly virulent and more infectious pathogen [55]. Low selenium levels have been shown to increase the viral pathogenicity influenza virus and coxsackievirus and transform their genome from a nonvirulent to a virulent virus [56]. These genomic mutations alter the functioning of certain enzymes that regulate the levels of oxidative stress in the body, ultimately leading to tissue and organ damage [57,58].
Selenium, along with ginseng saponins, has been reported to lead to the upregulation of the reaction to a live infectious coronavirus vaccine against avian coronavirus (IBV) in chickens [59]. A recent study showed that selenium plays a particular role in ACE inhibition, suggesting its beneficial role against COVID-19 [60]. In another study, it is suggested that the preinfectious level of zinc and selenium may be of a particular significance in terms of resistance to COVID-19 progression [61]. Such findings indicate that the use of selenium supplements can help in the treatment of COVID-19. The immune effect of selenium is attributed to its role in selenoproteins (selenium-dependent enzymes) that regulate the level of oxidative stress in the body [47]. The selenoproteins mediate the antioxidant defense system that controls the functioning of leukocytes. It is also involved in T lymphocyte proliferation and production of the immunoglobulins that protect the body against infections and diseases [62].

5. Vitamins and Immune System

5.1. Vitamin A

Vitamin A is present in the body in three active forms, retinoic acid, retinol, and retinal. It is a fundamental vitamin that is fat-soluble. Because of its widely known role in the immune system and its effectiveness against infections, vitamin A is considered an “anti-infective” vitamin [63]. The appropriate intake of vitamin A optimizes the body’s defense against microbes. Studies have shown that nutrient deficiencies are responsible for weakened immune responses [64]. The regular intake of vitamin A has been reported to decrease the infectivity and seriousness of many diseases, such as diarrhea, pneumonia, measles, malaria, and AIDS [65]. Vitamin A deficiency decreases bovine coronavirus vaccines’ efficiency and makes the animals more susceptible to infections [66,67]. It has been reported that the infectious bronchitis virus (IBV) infections caused by a strain similar to CoVs were more common in vitamin-A-deficient chickens than in those given vitamin A supplements [68]. The mechanism behind the protective effects of vitamin A against pathogens is its ability to upregulate specific components of innate immunity in healthy cells and fight against viral infection [69,70].
Vitamin A plays a functional and structural role in both the natural and acquired immune systems against several viruses. Supplementation of vitamin A may upregulates the immune system and helps to combat SARS-CoV-2 infections. However, clinical trials to establish the role of vitamin A against SARS-CoV-2 are ongoing (Table 1) [71]. It provides a physical defense by maintaining the structural barrier of mucosal cells in the skin, respiratory tract, and digestive tract. An adequate amount of vitamin A is essential for the optimal functioning of immune cells, including natural killer cells and macrophages, which are components of the innate immunity. Vitamin A helps to ensure the proper functioning of lymphocytes and produce an antibody response against an antigen [47]. It controls the antigen-presenting cells and maintains the balance between Th1 and Th2 lymphocytes [72]. Thus, vitamin A represents a promising alternative to counteract the novel coronavirus’s deleterious effects and prevent lung damage.

5.2. Vitamin B

Vitamin B regulates the inflammatory response [73]. B vitamins act as vital cofactors in various cellular reactions and mediate the synthesis of amino acids, the basic structural units of antibodies and cytokines. They play substantial roles in the proliferation and maturation of lymphocytes, which are part of the primary immune response [47]. There are different types of B vitamins (B2, B3, B6, and B12), and they are water-soluble and primarily function as coenzymes in various vital processes in the body. Each B vitamin has a unique function and plays a vital role in immunity to combat infections. For example, vitamin B2, also known as riboflavin, is involved in cellular energy-yielding metabolic processes [74]. It has been shown that UV light and vitamin B2 efficiently decrease the level of MERS-CoV in the human body [75].
Nicotinamide, also known as vitamin B3, enhances the destruction of Staphylococcus aureus by upregulating specific genes [76]. In silico studies suggest the effect of vitamin B12 has an inhibitory effect on RNA-dependent RNA polymerase activity of the SARS-CoV-2 virus, the main enzyme involved in viral replication [77,78]. Pyridoxal 5′-phosphate, the active form of vitamin B6, is involved in protein, carbohydrate, and lipid metabolism and is involved in more than one hundred reactions in the body. Recent research has revealed that the vitamin B6-derived bananin (BAN) has inhibitory effects on the SARS-helicase enzyme, which hinders the viral replication process [79]. Vitamins B6, B12, and B9 (folic acid) enhance natural killer cell activity, which provides an important antiviral defense [80]. These findings suggest that B vitamins have the potential to limit the complication related to COVID-19 infection [81]. In view of the studies mentioned above, it is obvious that vitamin B has a crucial role in regulating the inflammatory response, amino acid synthesis, and the proliferation of lymphocytes.

5.3. Vitamin C

Vitamin C (ascorbic acid) is water-soluble, and it plays a significant structural role in the synthesis of collagen, a component of human connective tissues, and is also a powerful antioxidant. Its main function is related to immunity, and it has been shown to protect against various infections, including coronavirus infections [82]. For example, vitamin C can improve the resistance of cultured chick embryos against avian coronavirus infections [83]. This vitamin has antihistamine effects and can relieve flulike symptoms, including runny nose, congestion, sneezing, and inflamed sinuses [84,85]. Human trials have reported a significant decrease in pneumonia incidence when increased doses of vitamin C were given in the diet. This finding suggests that vitamin C has great potential to decrease the vulnerability to lower respiratory tract infections [82]. A clinical trial in the USA reported that intravenous (IV) doses of vitamin C decreased sepsis-induced ARDS death rate. The development of ARDS in patients with COVID-19 is a critical complication that leads to mortality [86].
Recent studies recommended the consumption of vitamin C to control lower respiratory tract infections, and vitamin C supplementation represents one of the most compelling therapeutic interventions for COVID-19 [87,88,89,90]. Vitamin C’s primary function in the immune response against infections is to act as a potent antioxidant. Ascorbic acid is a cofactor for various enzymes involved in biosynthesis and gene regulation processes [39]. Vitamin C mediates the immune response through many cellular functions of the acquired and innate immune systems. Vitamin C provides an epithelial barrier against various pathogenic organisms. It increases the oxidant-scavenging ability of the skin to help to protect against oxidative stress. Vitamin C enhances the chemotactic ability of phagocytic cells, which increases the phagocytosis of invading microbes. It has been shown that vitamin C plays a pivotal role in removing old neutrophils from infection sites and decreasing the potential damage to infected tissues [91]. A randomized clinical trial (NCT04264533) in China is underway in which approximately 140 cases infected with SARS-CoV-2 will be given IV vitamin C (24 g/day for seven days), and it is hoped that the results will be available in September 2020 [92].

5.4. Vitamin D

Vitamin D plays dual roles in the body as a nutrient and a hormone. It is produced in response to sunlight and maintains the health of bones. It stimulates the growth and maturation of several cells, including immune cells, and plays a crucial role in immune functions [93]. A significant cause of vitamin D deficiency is sunlight deprivation, particularly in older people who stay indoors [94]. The majority of the COVID-19 cases are middle-aged to older individuals who have inadequate vitamin D levels. Vitamin D deficiency in calves is linked with increased susceptibility to bovine coronavirus infection [95]. Recent research reports have highlighted the role of vitamin D as a potent immunomodulator to combat influenza and COVID-19. It has been suggested that supplementation of vitamin D at an oral dose of 200,000 to 300,000 international units (IU) and other micronutrients for a week can strengthen the immune system against COVID-19 [96,97]. An observational study also demonstrated an inverse relationship between the critical outcome of COVID-19 and serum levels of 25 hydroxyvitamin D (25(OH)D) [98]. However, in contrast, a study from the UK reported no statistical relationship between serum 25(OH) D level and COVID-19 [99].
The physiological role of vitamin D in fighting against infections and diseases has been widely studied. Recently, vitamin D was found to reduce the risk of the common cold and other similar viral infections. It was found that vitamin D helps the immune system in three ways: (i) providing a physical barrier, (ii) strengthening natural immunity, and (iii) strengthening adaptive immunity [100]. 1,25-dihydroxy vitamin D improves the physical barrier that protects against infections. The active hormone encodes proteins that maintain the adherens junctions, tight junctions, and gap junctions in epithelial cells. These proteins strengthen the barrier by holding cells together and improving cell-to-cell communication [101]. It enhances the innate cellular immunity by mediating the release of antimicrobial compounds, including 1,25-dihydroxy vitamin D [5]. Vitamin D also improves the cellular immune system by controlling the “cytokine storm” produced in response to natural immunity. The innate immune response produces inflammatory cytokines against viral infections, including COVID-19. Vitamin D can also decrease the tissue damage induced by the “cytokine storm” [102]. A recent study reported that the crucial molecular virulence mechanisms of COVID-19 infection are based on the interaction of human DPP4/CD26 with spike glycoprotein S1 of SARS-CoV-2 [103]. Optimal vitamin D levels may attenuate this virulent mechanism. In vivo studies have shown that the expression of DPP4/CD26 was significantly reduced after the correction of 25(OH)D deficiency [104]. These findings suggest that vitamin D supplementation is promising for the management of this new viral disease.

5.5. Vitamin E

Vitamin E is fat-soluble and is one of the most important vitamins to maintain the immune system [105]. It is a powerful antioxidant and can reduce the levels of oxidative stress in the body by sequestering free radicals [106]. Vitamin E deficiency was found to increase the myocardial injury caused by an RNA viral (coxsackievirus B3) infection in mice, as the viral strains become more virulent under oxidative stress [107]. Likewise, vitamin E deficiency in calves was linked to a high risk of bovine coronavirus infection [95].
Vitamin E is a potent antioxidant that protects the cell membrane from damage by free radicals. It has been stated that vitamin E plays an essential role in enhancing the production of natural killer cells and interleukins. It significantly contributes to the proliferation of lymphocytes and elicits a robust immune reaction against pathogens [25]. These findings support the potential therapeutic use of vitamin E against COVID-19.

6. Conclusions and Future Directions

This review summarizes the potential nutritional interventions available for various coronaviruses that can be used to combat COVID-19 (Figure 2). Several studies have reported that available nutritional interventions can significantly improve the host immune response against infections by RNA viruses. The supplementation of micronutrients in COVID-19 should not be confused with their administration in cases of their deficiencies. Moreover, nutritional deficiencies weaken the immune response in many model systems as well as in humans. These findings highlight the importance of assessing the nutritional status to identify potential risk factors for viral infections. It is suggested to do a dietary assessment at the time of administration of COVID-19 patients, which may help in the better outcome of treatment. Such compounds proven to be efficient remedies for MERS and SARS may be used to manage COVID-19 and develop new SARS-CoV-2 medications. In contrast to previous research based on a single micronutrient, our analysis focuses on up-to-date awareness of the use of minerals and vitamins and their potential role in the immune system. Moreover, some studies focused on the effect of specific diet patterns, probiotics, and medicinal herbs. Our study is different as we individually discussed the significance of each mineral and vitamin and its potential role in preventing COVID-19 in view of the recently updated scientific information.
This review has several limitations. First, some micronutrients have not yet been shown to have a direct effect on SARS-CoV-2, so the data used in this review were predominantly from studies on related viruses, such as SARS and MERS. Second, most clinical trials to assess these micronutrients are still in progress, and results are not currently available. The results of these clinical trials are thus necessary to determine the direct impact of micronutrients on SARS-CoV-2 and establish safe doses. Additional prospective clinical trials are needed to address these speculations and enhance the knowledge about the association between micronutrients and COVID-19.

Author Contributions

K.J., H.E., H.Y. and A.R. designed the study and reviewed the literature; S.Y., S.S.M.H., and H.Y. reviewed and analyzed the literature; K.J., H.E., A.E.A., K.O.A.A. and M.I.U. prepared the table, figures, and first draft. K.J., H.E. and A.R. final revision. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We are thankful to the Deanship of Scientific Research, Jouf University, Saudi Arabia, for continuous inspiration.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Banerjee, A.; Kulcsar, K.; Misra, V.; Frieman, M.; Mossman, K. Bats and Coronaviruses. Viruses 2019, 11, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Chen, Y.; Liu, Q.; Guo, D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020, 92, 418–423. [Google Scholar] [CrossRef] [PubMed]
  3. Schoeman, D.; Fielding, B.C. Coronavirus envelope protein: Current knowledge. Virol. J. 2019, 16, 69. [Google Scholar] [CrossRef] [Green Version]
  4. Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733. [Google Scholar] [CrossRef] [PubMed]
  5. Adams, J.S.; Ren, S.; Liu, P.T.; Chun, R.F.; Lagishetty, V.; Gombart, A.F.; Borregaard, N.; Modlin, R.L.; Hewison, M. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 2009, 182, 4289–4295. [Google Scholar] [CrossRef] [Green Version]
  6. Calder, P.C.; Carr, A.C.; Eggersdorfer, M.; Gombart, A.F. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients 2020, 12, 1181. [Google Scholar] [CrossRef] [Green Version]
  7. Karim, T.; Muhit, M.; Khandaker, G. Interventions to prevent respiratory diseases—Nutrition and the developing world. Paediatr. Respir. Rev. 2017, 22, 31–37. [Google Scholar] [CrossRef]
  8. WHO. COVID-19 Studies from the World Health Organization Database; WHO: Geneva, Switzerland, 2020.
  9. Xu, Z.; Shi, L.; Wang, Y.; Zhang, J.; Huang, L.; Zhang, C.; Liu, S.; Zhao, P.; Liu, H.; Zhu, L.; et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020, 8, 420–422. [Google Scholar] [CrossRef]
  10. Yan, R.; Zhang, Y.; Guo, Y.; Zhou, Q.; Li, Y.; Xia, L. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020, 367, 1444–1448. [Google Scholar] [CrossRef] [Green Version]
  11. Chen, L.; Hao, G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc. Res. 2020. [Google Scholar] [CrossRef]
  12. Li, G.; Fan, Y.; Lai, Y.; Han, T.; Li, Z.; Zhou, P.; Pan, P.; Wang, W.; Hu, D.; Liu, X.; et al. Coronavirus infections and immune responses. J. Med. Virol. 2020, 92, 424–432. [Google Scholar] [CrossRef] [PubMed]
  13. Dai, X.; Hakizimana, O.; Zhang, X.; Kaushik, A.C.; Zhang, J. Orchestrated efforts on host network hijacking: Processes governing virus replication. Virulence 2020, 11, 183–198. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Zhou, P.; Yang, X.L.; Wang, X.G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Mathew, D.; Giles, J.R.; Baxter, A.E.; Greenplate, A.R.; Wu, J.E.; Alanio, C.; Oldridge, D.A.; Kuri-Cervantes, L.; Pampena, M.B.; D’Andrea, K.; et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. BioRxiv 2020. [Google Scholar] [CrossRef]
  16. Kuri-Cervantes, L.; Pampena, M.B.; Meng, W.; Rosenfeld, A.M.; Ittner, C.A.G.; Weisman, A.R.; Agyekum, R.; Mathew, D.; Baxter, A.E.; Vella, L.; et al. Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection. BioRxiv 2020. [Google Scholar] [CrossRef]
  17. Tay, M.Z.; Poh, C.M.; Rénia, L.; MacAry, P.A.; Ng, L.F.P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 2020, 20, 363–374. [Google Scholar] [CrossRef]
  18. Pae, M.; Wu, D. Nutritional modulation of age-related changes in the immune system and risk of infection. Nutr. Res. 2017, 41, 14–35. [Google Scholar] [CrossRef] [Green Version]
  19. Zabetakis, I.; Lordan, R.; Tsoupras, A.; Norton, C. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients 2020, 12, 1466. [Google Scholar] [CrossRef]
  20. Mao, R.; Liang, J.; Shen, J.; Ghosh, S.; Zhu, L.R.; Yang, H.; Wu, K.C.; Chen, M.H. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol. Hepatol. 2020, 5, 425–427. [Google Scholar] [CrossRef]
  21. Hu, Y.; Sun, J.; Dai, Z.; Deng, H.; Li, X.; Huang, Q.; Wu, Y.; Sun, L.; Xu, Y. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J. Clin. Virol. 2020, 127, 104371. [Google Scholar] [CrossRef]
  22. Ejaz, H.; Alsrhani, A.; Zafar, A.; Javed, H.; Junaid, K.; Abdalla, A.E.; Abosalif, K.O.A.; Ahmed, Z.; Younas, S. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health 2020. [Google Scholar] [CrossRef] [PubMed]
  23. Wu, R.; Wang, L.; Kuo, H.D.; Shannar, A.; Peter, R.; Chou, P.J.; Li, S.; Hudlikar, R.; Liu, X.; Liu, Z.; et al. An Update on Current Therapeutic Drugs Treating COVID-19. Curr. Pharmacol. Rep. 2020, 2020, 1–15. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, L.; Liu, Y. Potential interventions for novel coronavirus in China: A systematic review. J. Med. Virol. 2020, 92, 479–490. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Gombart, A.F.; Pierre, A.; Maggini, S. A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection. Nutrients 2020, 12, 236. [Google Scholar] [CrossRef] [Green Version]
  26. Casas, R.; Estruch, R.; Sacanella, E. The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses. Endocr. Met. B Immune. Disord. Drug Targets 2018, 18, 23–35. [Google Scholar] [CrossRef]
  27. Yimit, D.; Hoxur, P.; Amat, N.; Uchikawa, K.; Yamaguchi, N. Effects of soybean peptide on immune function, brain function, and neurochemistry in healthy volunteers. Nutrition 2012, 28, 154–159. [Google Scholar] [CrossRef]
  28. Locke, A.; Schneiderhan, J.; Zick, S.M. Diets for Health: Goals and Guidelines. Am. Fam. Physician 2018, 97, 721–728. [Google Scholar]
  29. Bonaventura, P.; Benedetti, G.; Albarède, F.; Miossec, P. Zinc and its role in immunity and inflammation. Autoimmun. Rev. 2015, 14, 277–285. [Google Scholar] [CrossRef]
  30. Maares, M.; Haase, H. Zinc and immunity: An essential interrelation. Arch. Biochem. Biophys. 2016, 611, 58–65. [Google Scholar] [CrossRef]
  31. Awotiwon, A.A.; Oduwole, O.; Sinha, A.; Okwundu, C.I. Zinc supplementation for the treatment of measles in children. Cochrane Database Syst. Rev. 2017, 6, Cd011177. [Google Scholar] [CrossRef] [Green Version]
  32. Chiu, H.P.; Chiu, H.; Yang, C.F.; Lee, Y.L.; Lin, Y.L. Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein. PLoS Pathog. 2018, 14, e1007166. [Google Scholar] [CrossRef] [PubMed]
  33. Raza, N.; Khan, D.A. Zinc deficiency in patients with persistent viral warts. J. Coll. Physicians Surg. Pak. 2010, 20, 83–86. [Google Scholar] [PubMed]
  34. te Velthuis, A.J.; van den Worm, S.H.; Sims, A.C.; Baric, R.S.; Snijder, E.J.; van Hemert, M.J. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010, 6, e1001176. [Google Scholar] [CrossRef] [PubMed]
  35. Zhang, H.; Penninger, J.M.; Li, Y.; Zhong, N.; Slutsky, A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020, 46, 586–590. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Skalny, A.V.; Rink, L.; Ajsuvakova, O.P.; Aschner, M.; Gritsenko, V.A.; Alekseenko, S.I.; Svistunov, A.A.; Petrakis, D.; Spandidos, D.A.; Aaseth, J.; et al. Zinc and respiratory tract infections: Perspectives for COVID-19. Int. J. Mol. Med. 2020, 46, 17–26. [Google Scholar] [CrossRef] [Green Version]
  37. Speth, R.; Carrera, E.; Jean-Baptiste, M.; Joachim, A.; Linares, A. Concentration-dependent effects of zinc on angiotensin-converting enzyme-2 activity. FASEB J. 2014, 28, 1067.42014. [Google Scholar]
  38. Finzi, E. Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients. Int. J. Infect. Dis. 2020, 99, 307–309. [Google Scholar] [CrossRef]
  39. Wintergerst, E.S.; Maggini, S.; Hornig, D.H. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann. Nutr. Metab. 2006, 50, 85–94. [Google Scholar] [CrossRef] [Green Version]
  40. Biaggio, V.S.; Salvetti, N.R.; Pérez Chaca, M.V.; Valdez, S.R.; Ortega, H.H.; Gimenez, M.S.; Gomez, N.N. Alterations of the extracellular matrix of lung during zinc deficiency. Br. J. Nutr. 2012, 108, 62–70. [Google Scholar] [CrossRef] [Green Version]
  41. Kahmann, L.; Uciechowski, P.; Warmuth, S.; Plümäkers, B.; Gressner, A.M.; Malavolta, M.; Mocchegiani, E.; Rink, L. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res. 2008, 11, 227–237. [Google Scholar] [CrossRef]
  42. Bin, B.H.; Hojyo, S.; Seo, J.; Hara, T.; Takagishi, T.; Mishima, K.; Fukada, T. The Role of the Slc39a Family of Zinc Transporters in Zinc Homeostasis in Skin. Nutrients 2018, 10, 219. [Google Scholar] [CrossRef] [Green Version]
  43. Kehl-Fie, T.E.; Skaar, E.P. Nutritional immunity beyond iron: A role for manganese and zinc. Curr. Opin. Chem. Biol. 2010, 14, 218–224. [Google Scholar] [CrossRef] [Green Version]
  44. Weiss, G. Iron and immunity: A double-edged sword. Eur. J. Clin. Investig. 2002, 32 (Suppl. 1), 70–78. [Google Scholar] [CrossRef]
  45. Wessling-Resnick, M. Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry. Annu. Rev. Nutr. 2018, 38, 431–458. [Google Scholar] [CrossRef]
  46. Jayaweera, J.; Reyes, M.; Joseph, A. Childhood iron deficiency anemia leads to recurrent respiratory tract infections and gastroenteritis. Sci. Rep. 2019, 9, 12637. [Google Scholar] [CrossRef] [Green Version]
  47. Maggini, S.; Pierre, A.; Calder, P.C. Immune Function and Micronutrient Requirements Change over the Life Course. Nutrients 2018, 10, 1531. [Google Scholar] [CrossRef] [Green Version]
  48. Bellmann-Weiler, R.; Lanser, L.; Fritsche, G.; Wöll, E.; Rangger, L.; Schapfl, A.; Schaber, M.; Weiss, G.; Barket, R. Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection. J. Clin. Med. 2020, 9, 2429. [Google Scholar] [CrossRef]
  49. Paikaray, S. Origin, mobilization and distribution of selenium in a soil/water/air system: A global perspective with special reference to the Indian scenario. CLEAN–Soil Air Water 2016, 44, 474–487. [Google Scholar] [CrossRef]
  50. Smrkolj, P.; Pograjc, L.; Hlastan-Ribič, C.; Stibilj, V. Selenium content in selected Slovenian foodstuffs and estimated daily intakes of selenium. Food Chem. 2005, 90, 691–697. [Google Scholar] [CrossRef]
  51. Kieliszek, M. Selenium–fascinating microelement, properties and sources in food. Molecules 2019, 24, 1298. [Google Scholar] [CrossRef] [Green Version]
  52. Rayman, M.P. Selenium and human health. Lancet 2012, 379, 1256–1268. [Google Scholar] [CrossRef]
  53. Beck, M.A.; Matthews, C.C. Micronutrients and host resistance to viral infection. Proc. Nutr. Soc. 2000, 59, 581–585. [Google Scholar] [CrossRef]
  54. Guillin, O.M.; Vindry, C.; Ohlmann, T.; Chavatte, L. Selenium, Selenoproteins and Viral Infection. Nutrients 2019, 11, 2101. [Google Scholar] [CrossRef] [Green Version]
  55. Harthill, M. Review: Micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol. Trace Elem. Res. 2011, 143, 1325–1336. [Google Scholar] [CrossRef]
  56. Beck, M.A.; Nelson, H.K.; Shi, Q.; Van Dael, P.; Schiffrin, E.J.; Blum, S.; Barclay, D.; Levander, O.A. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J. 2001, 15, 1481–1483. [Google Scholar] [CrossRef]
  57. Beck, M.A.; Shi, Q.; Morris, V.C.; Levander, O.A. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1995, 1, 433–436. [Google Scholar] [CrossRef]
  58. Fradejas-Villar, N. Consequences of mutations and inborn errors of selenoprotein biosynthesis and functions. Free Radic. Biol. Med. 2018, 127, 206–214. [Google Scholar] [CrossRef]
  59. Ma, X.; Bi, S.; Wang, Y.; Chi, X.; Hu, S. Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens. Poult. Sci. 2019, 98, 3548–3556. [Google Scholar] [CrossRef]
  60. Seko, T.; Imamura, S.; Ishihara, K.; Yamashita, Y.; Yamashita, M. Inhibition of angiotensin-converting enzyme by selenoneine. Fish. Sci. 2019, 85, 731–736. [Google Scholar] [CrossRef] [Green Version]
  61. Alexander, J.; Tinkov, A.; Strand, T.A.; Alehagen, U.; Skalny, A.; Aaseth, J. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients 2020, 12, 2358. [Google Scholar] [CrossRef]
  62. Tinggi, U. Selenium: Its role as antioxidant in human health. Environ. Health Prev. Med. 2008, 13, 102–108. [Google Scholar] [CrossRef] [Green Version]
  63. Huang, Z.; Liu, Y.; Qi, G.; Brand, D.; Zheng, S.G. Role of Vitamin A in the Immune System. J. Clin. Med. 2018, 7, 258. [Google Scholar] [CrossRef] [Green Version]
  64. Kańtoch, M.; Litwińska, B.; Szkoda, M.; Siennicka, J. Importance of vitamin A deficiency in pathology and immunology of viral infections. Rocz. Panstw. Zakl. Hig. 2002, 53, 385–392. [Google Scholar]
  65. Villamor, E.; Mbise, R.; Spiegelman, D.; Hertzmark, E.; Fataki, M.; Peterson, K.E.; Ndossi, G.; Fawzi, W.W. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. Pediatrics 2002, 109, E6. [Google Scholar] [CrossRef] [Green Version]
  66. Jee, J.; Hoet, A.E.; Azevedo, M.P.; Vlasova, A.N.; Loerch, S.C.; Pickworth, C.L.; Hanson, J.; Saif, L.J. Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. Am. J. Vet. Res. 2013, 74, 1353–1362. [Google Scholar] [CrossRef]
  67. Stachowska, E.; Folwarski, M.; Jamioł-Milc, D.; Maciejewska, D.; Skonieczna-Żydecka, K. Nutritional Support in Coronavirus 2019 Disease. Medicine 2020, 56, 289. [Google Scholar]
  68. West, C.E.; Sijtsma, S.R.; Kouwenhoven, B.; Rombout, J.H.; van der Zijpp, A.J. Epithelia-damaging virus infections affect vitamin A status in chickens. J. Nutr. 1992, 122, 333–339. [Google Scholar] [CrossRef]
  69. Trottier, C.; Colombo, M.; Mann, K.K.; Miller, W.H., Jr.; Ward, B.J. Retinoids inhibit measles virus through a type I IFN-dependent bystander effect. FASEB J. 2009, 23, 3203–3212. [Google Scholar] [CrossRef]
  70. Katze, M.G.; Fornek, J.L.; Palermo, R.E.; Walters, K.A.; Korth, M.J. Innate immune modulation by RNA viruses: Emerging insights from functional genomics. Nat. Rev. Immunol. 2008, 8, 644–654. [Google Scholar] [CrossRef]
  71. Beigmohammadi, M.T.; Bitarafan, S.; Hoseindokht, A.; Abdollahi, A.; Amoozadeh, L.; Mahmoodi Ali Abadi, M.; Foroumandi, M. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: A structured summary of a study protocol for a randomized controlled trial. Trials 2020, 21, 614. [Google Scholar] [CrossRef]
  72. Ross, A.C. Vitamin A deficiency and retinoid repletion regulate the antibody response to bacterial antigens and the maintenance of natural killer cells. Clin. Immunol. Immunopathol. 1996, 80, S63–S72. [Google Scholar] [CrossRef]
  73. Morris, M.S.; Sakakeeny, L.; Jacques, P.F.; Picciano, M.F.; Selhub, J. Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status. J. Nutr. 2010, 140, 103–110. [Google Scholar] [CrossRef] [Green Version]
  74. Spinas, E.; Saggini, A.; Kritas, S.K.; Cerulli, G.; Caraffa, A.; Antinolfi, P.; Pantalone, A.; Frydas, A.; Tei, M.; Speziali, A.; et al. Crosstalk between Vitamin B and Immunity. J. Biol. Regul. Homeost Agents 2015, 29, 283–288. [Google Scholar]
  75. Bashandy, S.A.E.; Ebaid, H.; Abdelmottaleb Moussa, S.A.; Alhazza, I.M.; Hassan, I.; Alaamer, A.; Al Tamimi, J. Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide. Lipids Health Dis. 2018, 17, 29. [Google Scholar] [CrossRef] [Green Version]
  76. Kyme, P.; Thoennissen, N.H.; Tseng, C.W.; Thoennissen, G.B.; Wolf, A.J.; Shimada, K.; Krug, U.O.; Lee, K.; Müller-Tidow, C.; Berdel, W.E.; et al. C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice. J. Clin. Investig. 2012, 122, 3316–3329. [Google Scholar] [CrossRef] [Green Version]
  77. Wu, C.; Liu, Y.; Yang, Y.; Zhang, P.; Zhong, W.; Wang, Y.; Wang, Q.; Xu, Y.; Li, M.; Li, X.; et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020, 10, 766–788. [Google Scholar] [CrossRef]
  78. Narayanan, N.; Nair, D.T. Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 Virus. Preprints 2020. Available online: https://indiarxiv.org/p48fa/ (accessed on 5 September 2020). [CrossRef] [Green Version]
  79. Tanner, J.A.; Zheng, B.J.; Zhou, J.; Watt, R.M.; Jiang, J.Q.; Wong, K.L.; Lin, Y.P.; Lu, L.Y.; He, M.L.; Kung, H.F.; et al. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem. Biol. 2005, 12, 303–311. [Google Scholar] [CrossRef] [Green Version]
  80. Yoshii, K.; Hosomi, K.; Sawane, K.; Kunisawa, J. Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity. Front. Nutr. 2019, 6, 48. [Google Scholar] [CrossRef] [Green Version]
  81. Tan, C.W.; Ho, L.P.; Kalimuddin, S.; Cherng, B.P.Z.; Teh, Y.E.; Thien, S.Y.; Wong, H.M.; Tern, P.J.W.; Chandran, M.; Chay, J.W.M. A cohort study to evaluate the effect of combination Vitamin D, Magnesium and Vitamin B12 on progression to severe outcome in older COVID-19 patients. Nutrition 2020, 111017. [Google Scholar] [CrossRef]
  82. Hemilä, H. Vitamin C and SARS coronavirus. J. Antimicrob. Chemother. 2003, 52, 1049–1050. [Google Scholar] [CrossRef] [Green Version]
  83. Atherton, J.G.; Kratzing, C.C.; Fisher, A. The effect of ascorbic acid on infection chick-embryo ciliated tracheal organ cultures by coronavirus. Arch. Virol. 1978, 56, 195–199. [Google Scholar] [CrossRef] [Green Version]
  84. Field, C.J.; Johnson, I.R.; Schley, P.D. Nutrients and their role in host resistance to infection. J. Leukoc. Biol. 2002, 71, 16–32. [Google Scholar]
  85. Hemilä, H. Vitamin C intake and susceptibility to the common cold. Br. J. Nutr. 1997, 77, 59–72. [Google Scholar] [CrossRef] [Green Version]
  86. Fowler, A.A., 3rd; Truwit, J.D.; Hite, R.D.; Morris, P.E.; DeWilde, C.; Priday, A.; Fisher, B.; Thacker, L.R., 2nd; Natarajan, R.; Brophy, D.F.; et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA 2019, 322, 1261–1270. [Google Scholar] [CrossRef]
  87. Matthay, M.A.; Aldrich, J.M.; Gotts, J.E. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir. Med. 2020, 8, 433–434. [Google Scholar] [CrossRef] [Green Version]
  88. Zhang, J.; Xie, B.; Hashimoto, K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain. Behav. Immun. 2020, 87, 59–73. [Google Scholar] [CrossRef]
  89. Colunga Biancatelli, R.M.L.; Berrill, M.; Catravas, J.D.; Marik, P.E. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Front. Immunol. 2020, 11, 1451. [Google Scholar] [CrossRef]
  90. Liu, F.; Zhu, Y.; Zhang, J.; Li, Y.; Peng, Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: Study protocol for a multicentre randomised controlled trial. BMJ Open 2020, 10, e039519. [Google Scholar] [CrossRef]
  91. Carr, A.C.; Maggini, S. Vitamin C and Immune Function. Nutrients 2017, 9, 1211. [Google Scholar] [CrossRef] [Green Version]
  92. Carr, A.C. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit. Care 2020, 24, 133. [Google Scholar] [CrossRef] [Green Version]
  93. Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. Vitamin D: Modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10, 482–496. [Google Scholar] [CrossRef]
  94. Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80, 1678s–1688s. [Google Scholar] [CrossRef] [Green Version]
  95. Nonnecke, B.J.; McGill, J.L.; Ridpath, J.F.; Sacco, R.E.; Lippolis, J.D.; Reinhardt, T.A. Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves. J. Dairy Sci. 2014, 97, 5566–5579. [Google Scholar] [CrossRef] [Green Version]
  96. Grant, W.B.; Lahore, H.; McDonnell, S.L.; Baggerly, C.A.; French, C.B.; Aliano, J.L.; Bhattoa, H.P. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020, 12, 988. [Google Scholar] [CrossRef] [Green Version]
  97. Ebadi, M.; Montano-Loza, A.J. Perspective: Improving vitamin D status in the management of COVID-19. Eur. J. Clin. 2020, 74, 856–859. [Google Scholar] [CrossRef]
  98. Panagiotou, G.; Tee, S.A.; Ihsan, Y.; Athar, W.; Marchitelli, G.; Kelly, D.; Boot, C.S.; Stock, N.; Macfarlane, J.; Martineau, A.R.; et al. Low serum 25-hydroxyvitamin D (25 [OH] D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin. Endocrinol. 2020. [Google Scholar] [CrossRef]
  99. Hastie, C.E.; Mackay, D.F.; Ho, F.; Celis-Morales, C.A.; Katikireddi, S.V.; Niedzwiedz, C.L.; Jani, B.D.; Welsh, P.; Mair, F.S.; Gray, S.R.; et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab. Syndr. 2020, 14, 561–565. [Google Scholar] [CrossRef]
  100. Schwalfenberg, G.K. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 2011, 55, 96–108. [Google Scholar] [CrossRef]
  101. Rondanelli, M.; Miccono, A.; Lamburghini, S.; Avanzato, I.; Riva, A.; Allegrini, P.; Faliva, M.A.; Peroni, G.; Nichetti, M.; Perna, S. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evid. Based Complement. Altern. Med. 2018, 2018, 5813095. [Google Scholar]
  102. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
  103. Vankadari, N.; Wilce, J.A. Emerging WuHan (COVID-19) coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg. Microbes Infect. 2020, 9, 601–604. [Google Scholar] [CrossRef] [PubMed]
  104. Komolmit, P.; Charoensuk, K.; Thanapirom, K.; Suksawatamnuay, S.; Thaimai, P.; Chirathaworn, C.; Poovorawan, Y. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial. PLoS ONE 2017, 12, e0174608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Lee, G.Y.; Han, S.N. The Role of Vitamin E in Immunity. Nutrients 2018, 10, 1614. [Google Scholar] [CrossRef] [Green Version]
  106. Galmés, S.; Serra, F.; Palou, A. Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances. Nutrients 2018, 10, 1919. [Google Scholar] [CrossRef] [Green Version]
  107. Beck, M.A.; Kolbeck, P.C.; Rohr, L.H.; Shi, Q.; Morris, V.C.; Levander, O.A. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J. Nutr. 1994, 124, 345–358. [Google Scholar] [CrossRef]
Nutrients 12 02992 g001 550
Figure 1. Schematic representation of processes used by the host immune system to combat COVID-19. The antigen-presenting cells (dendritic cells and macrophages) present the virus to naïve Th cells and stimulate the adaptive immune system. T cells also signal monocytes and macrophages to attract them to the infection site, where they release chemokines. Toll-like receptors (TLR) present on antigen-presenting cells recognize specific receptors on the virus and secrete inflammatory markers in innate immune system response. Mast cells activated by the pathogen release proinflammatory markers, proteases, and histamines. The upregulated secretion of proinflammatory markers causes a cytokine storm. IL-1 = interleukin 1; IL-2 = interleukin 2; IL-12 = interleukin 12; IL-4 = interleukin 4; IL-5 = interleukin 5; IL-6 = interleukin 6; IL-10 = interleukin 10, IFN-γ = interferon gamma; TNF-α = tumor necrosis factor alpha; CTL = cytotoxic T lymphocytes; NK = natural killer; C3a = complement component 3a; and C5a = complement component 5a.
Figure 1. Schematic representation of processes used by the host immune system to combat COVID-19. The antigen-presenting cells (dendritic cells and macrophages) present the virus to naïve Th cells and stimulate the adaptive immune system. T cells also signal monocytes and macrophages to attract them to the infection site, where they release chemokines. Toll-like receptors (TLR) present on antigen-presenting cells recognize specific receptors on the virus and secrete inflammatory markers in innate immune system response. Mast cells activated by the pathogen release proinflammatory markers, proteases, and histamines. The upregulated secretion of proinflammatory markers causes a cytokine storm. IL-1 = interleukin 1; IL-2 = interleukin 2; IL-12 = interleukin 12; IL-4 = interleukin 4; IL-5 = interleukin 5; IL-6 = interleukin 6; IL-10 = interleukin 10, IFN-γ = interferon gamma; TNF-α = tumor necrosis factor alpha; CTL = cytotoxic T lymphocytes; NK = natural killer; C3a = complement component 3a; and C5a = complement component 5a.
Nutrients 12 02992 g001
Nutrients 12 02992 g002 550
Figure 2. Mechanism of action of micronutrients against CoVs. NK = natural killer; ACE-2 = angiotensin-converting enzyme 2.
Figure 2. Mechanism of action of micronutrients against CoVs. NK = natural killer; ACE-2 = angiotensin-converting enzyme 2.
Nutrients 12 02992 g002
Table
Table 1. Examples of clinical trials on the use of vitamins against COVID-19 registered by the WHO [8].
Table 1. Examples of clinical trials on the use of vitamins against COVID-19 registered by the WHO [8].
Trial IDStudy DesignSample SizeSettingsIntervention in COVID-19 Patients
ChiCTR2000032400Cohort60ChinaHigh dose of vitamin C.
RCT20200401046909N1Randomized clinical trial260Iran1000 IUs of vitamin D daily for 8 weeks.
IRCT20180520039738N2Randomized clinical trial140IranVitamin A (25,000 IU/day) for 10 days.
DRKS00021214Randomized clinical trial1300GermanyVitamin B3 (nicotinamide) 1000 mg/day for 4 weeks.
EUCTR2020-001602-34-FRRandomized clinical trial260FranceA high dose of vitamin D (400,000 IU) versus a standard dose (50,000 IU) once daily for 14 days.
TCTR20200404004Randomized clinical trial400ThailandComparison of chloroquine, (10 mg base/kg) and vitamin C (1000 mg).
IRCT20170117032004N3Randomized clinical trial30IranVitamin A (50,000 IU) along with routine treatment for 2 weeks.
CTRI/2020/06/026189Randomized clinical trial210IndiaVitamin D (60,000 IU) single-dose and magnesium glycinate (250 mg bi-dose) for 14 days.
IRCT20200319046819N1Randomized clinical trial60IranVitamin A (25,000 IU), Vitamin D (600,000 IU) once during the intervention, Vitamin E (300 IU) twice daily, Vitamin C (500 mg) five times a day, and Vitamin B (Soluvit ampoule) daily.
NCT04335084Randomized clinical trial600USAHydroxychloroquine, Vitamin C, D, and Zinc.
NCT04264533Randomized clinical trial140ChinaVitamin C (12 g) twice a day for 7 days.
IU, International units.

Share and Cite

MDPI and ACS Style

Junaid, K.; Ejaz, H.; Abdalla, A.E.; Abosalif, K.O.A.; Ullah, M.I.; Yasmeen, H.; Younas, S.; Hamam, S.S.M.; Rehman, A. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020, 12, 2992. https://doi.org/10.3390/nu12102992

AMA Style

Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, Younas S, Hamam SSM, Rehman A. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients. 2020; 12(10):2992. https://doi.org/10.3390/nu12102992

Chicago/Turabian Style

Junaid, Kashaf, Hasan Ejaz, Abualgasim Elgaili Abdalla, Khalid O. A. Abosalif, Muhammad Ikram Ullah, Humaira Yasmeen, Sonia Younas, Sanaa S. M. Hamam, and Abdul Rehman. 2020. "Effective Immune Functions of Micronutrients against SARS-CoV-2" Nutrients 12, no. 10: 2992. https://doi.org/10.3390/nu12102992

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop